Genesco, Inc. (GCO) Reports Q1 Beat; Boosts FY13 Outlook
Tweet
Share
E-mailGet Alerts GCO Hot Sheet
Price: $35.07 +2.69%
EPS Growth %: -20.2%
Financial Fact:
Provision for discontinued operations, net: -53K
Today's EPS Names:
BTTX, VAXX, ELYS, More
EPS Growth %: -20.2%
Financial Fact:
Provision for discontinued operations, net: -53K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Genesco, Inc. (NYSE: GCO) reported Q1 EPS of $0.98, vs. the analyst estimate of $0.74. Revenue for the quarter came in at $600 million versus the consensus estimate of $577.11 million.
Sees FY2013 EPS of $4.70-$4.82, versus prior guidance of $4.58-$4.70 and the consensus of $4.69.
For earnings history and earnings-related data on Genesco, Inc. (GCO) click here.
Sees FY2013 EPS of $4.70-$4.82, versus prior guidance of $4.58-$4.70 and the consensus of $4.69.
For earnings history and earnings-related data on Genesco, Inc. (GCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
